Valuation: EMVision Medical Devices Ltd

Market Cap 145M 101M 89.55M 83.58M 76.18M 144M 9.69B 1.01B 392M 4.95B 378M 370M 15.9B P/E 2027 *
-13.8x
P/E 2028 * -12x
Enterprise Value 145M 101M 89.55M 83.58M 76.18M 144M 9.69B 1.01B 392M 4.95B 378M 370M 15.9B EV / Sales 2027 *
29x
EV / Sales 2028 * 17.1x
Free-Float
66.31%
Yield 2027 *
-
Yield 2028 * -
1 day-0.64%
1 week-10.34%
Current month-1.89%
1 month-11.11%
3 months+3.31%
6 months-2.50%
Current year-12.36%
1 week 1.54
Extreme 1.535
1.75
1 month 1.54
Extreme 1.535
1.9
Current year 1.47
Extreme 1.47
1.96
1 year 1.47
Extreme 1.47
1.96
3 years 1.44
Extreme 1.445
2.72
5 years 1.13
Extreme 1.13
3.35
10 years 0.28
Extreme 0.28
4.2
Manager TitleAgeSince
Chief Executive Officer - 2023-06-30
Director of Finance/CFO - 2026-01-31
Chief Tech/Sci/R&D Officer - 2023-06-30
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - 2018-06-30
Date Insider Type Main position Quantity % Market Cap. Importance
4/23/26 Buy

Director

10,000 0.0108%
1/2/26 Expiration

Chairman

300,000 0.3228%
11/18/25 Free

Director

200,000 0.2176%
Change 5-day change 1-year change 3-year change Capi.($)
-0.64%-10.34%-19.17%-4.29% 101M
+0.35%-2.99%+24.73%+32.07% 242B
+1.09%-4.65%+1.77%+0.15% 150B
-2.32%-3.27%-11.53%+32.87% 138B
-1.46%-3.01%-55.73%-19.33% 61.74B
-0.05%-1.32%+11.09%+23.08% 49.08B
+0.66%+0.19%-19.29%-21.24% 47.43B
+0.66%-2.90%+20.97%+51.29% 47.3B
-3.05%-2.62%-9.13%+35.86% 44.25B
-0.08%-1.92%+32.09%+57.18% 41.78B
Average -0.22%-3.29%-2.42%+18.76% 82.27B
Weighted average by Cap. +0.15%-3.27%+3.37%+21.48%

Financials

2027 *2028 *
Net sales 5M 3.48M 3.09M 2.88M 2.63M 4.95M 334M 34.87M 13.51M 171M 13.05M 12.76M 548M 8.5M 5.91M 5.25M 4.9M 4.47M 8.42M 568M 59.29M 22.97M 290M 22.18M 21.7M 932M
Net income -12M -8.34M -7.41M -6.92M -6.3M -11.89M -802M -83.7M -32.43M -410M -31.31M -30.63M -1.32B -14.5M -10.08M -8.95M -8.36M -7.62M -14.37M -969M -101M -39.19M -495M -37.84M -37.02M -1.59B
Net Debt - -
Logo EMVision Medical Devices Ltd
EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.
Employees
-
Date Price Change Volume
26-10-02 A$1.560 -0.64% 5,729
26-10-01 A$1.570 -1.26% 58,024
26-09-30 A$1.590 -1.85% 80,647
26-09-29 A$1.620 -4.71% 111,229
26-09-28 A$1.700 -2.30% 21,348
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.560AUD
Average target price
3.150AUD
Spread / Average Target
+101.92%

Annual profits - Rate of surprise